With the widespread use of tricyclic antidepressant drugs, the relationship between the concentration of the drug in the plasma and the therapeutic response is of considerable interest. We describe a double-isotope derivative dilution procedure for measuring plasma nortriptyline. In the method, [14C]nortriptyline is used for estimating procedural losses and [3H]acetic anhydride for derivative formation. The assay is rapid and adequately specific, sensitive, precise, and reproducible for routine clinical use.
concentrations in plasma of persons who were on a 150 mg/day dose of nortriptyline.
Intra-individual variation from day to day was 10-14%. This variation was not significantly affected by the dosage schedule, the time of sampling after an oral dose, or the storage of the plasma samples.
For 19 patients on 150 mg of nortriptyline per day, the mean concentration in plasma was 181 ± 22 (SE) ag/liter, a value that compares well with our previous findingsand those of other groups.
We reporta rapid double-isotopederivative dilution assay for measuring nortriptyline, based on a modification (1) of an isotope-derivative dilution assay (2). In the method ['4C]nortriptyline is used to correct for procedural losses and [8H]acetic anhydride for derivative formation.
Chromatography of the radiolabeled derivative has been included to improve specificity. The double-isotope derivative dilution assay has advantages over the isotope-derivative assay. Because each sample has its own recovery indicator, a standard curve for each assay is unnecessary, as is also the duplicate analysis of samples.
Moreover, the method has advantages over other currently available procedures such as gas-liquid chromatography (3-5) and massfragmentography (6, 7), both of which are more timeconsuming and require expensive, sophisticated equipment.
Suitable radioimmunoassay procedures have yet to be described. Measurement of plasma nortriptyline is important in monitoring an individual patient's therapeutic response because there can be large inter-individual differences for patients who are on the same dosage regimen. 
Materials and Methods

Extraction of Plasma Samples
Plasma samples (acidified with '/5-volume of 0.1 mol/liter HC1) were stored at -20 #{176}C until assay. Siliconized 7-ml glass-stoppered tubes were used in all steps.
After addition of [14C]nortriptyline (1.8 X 10 1sCi), 1-ml plasma samples were alkalinized with 0.4 ml of 1 mol/liter NaOH. Treated samples were gently extracted with 3 ml of n-heptane by rotation for 15 mm. Any emulsions were broken by freezing the samples in liquid nitrogen and allowing them to thaw. A 2-ml aliquot of each heptane extract was transferred to clean tubes for acetylation. The solvent was evaporated in an air stream and 2 ml of 0.1 mol/liter NaOH was added per sample. The stoppered tubes were returned to the 60 #{176}C water bath for 15 mm, then cooled to room temperature. n-Heptane, 2 ml, was added to each tube and the acetylated derivative extracted by rotation for 10 mm. After phase separation (about 10 mm), the aqueous phase was aspirated.
Derivative Formation
A further 2 ml of 0.1 mol/liter NaOH was added and the samples were rotated again for 10 mm. After phase separation, 1-ml aliquots of the heptane phase were transferred to clean tubes.
Thin-layer chromatography.
After addition of 10 tg of nortriptyline acetate (prepared by reacting nortriptyline with unlabeled acetic anhydride in a similar manner to that described above) as ultraviolet marker, we evaporated the solvent. The samples were applied to aluminum sheets precoated with silica-gel (20 cm X 20 cm X 0.25 mm, Silica-Gel GF254/5554; Merck) in three successive 0.2-ml portions of methanol in methylene chloride (40/60 by vol). Twelve samples were applied per sheet. The sheets were developed at room temperature in the ascending system benzene/acetone 1/1 by vol (2). The samples were located by the absorption of the added marker at 254 nm, and the appropriate area of the silica gel was scraped with the help of vacuum into glass "transpettes" (Clay-Adams) plugged with glass wool. Samples were eluted into glass vials by passing 10 ml of the methanol/methylene chloride mixture through the pipettes.
The solvent was evaporated and 10 ml of a phosphor solution was added 
Results
Analytical Variables
Precision.
Plasma pools of known nortriptyline concentration, 100 and 200 tg/liter, were used to evaluate the precision of the assay. In most patients treated clinically, concentrations of the drug in plasma lie between these values. The precision (CV) of the assay at the two concentrations was ±7%. Analysis of a quality-control sample (about 100 ng of nortriptyline per milliliter of water) in each assay gave a result of 90.4 ± 7.0 tg/liter (mean ± SD; n = 34) and a CV of 8%. Nortriptyline (about 200 ig/llter) was added to drug-free human plasma.
Half was stored frozen, half stored at room temperature. I-mI aliquots analyzed on the days shown. It appears that after separation of the plasma, the nortriptyline is stable for several days at room temperature (Table 2) . If kept frozen, no measurable change occurs during 120 days.
Discussion
For routine clinical use, an assay must be specific, sensitive, precise, and reproducible.
If possible, it should be simple, quick, and inexpensive.
The described double-isotope derivative dilution assay fulfills most of these requirements. Specificity was achieved by inclusion of a chromatography step, which adequately separates nortriptyline from its major plasma metabolites, lO-hydroxy-nortriptyline and desmethylnortriptyline
(17).
We found a close correlation between results obtained by this new 
